DE60010358D1 - Infectiösenbursalkrankheitsvirus (IBDV) die an Zellkultur angepasst sind - Google Patents

Infectiösenbursalkrankheitsvirus (IBDV) die an Zellkultur angepasst sind

Info

Publication number
DE60010358D1
DE60010358D1 DE60010358T DE60010358T DE60010358D1 DE 60010358 D1 DE60010358 D1 DE 60010358D1 DE 60010358 T DE60010358 T DE 60010358T DE 60010358 T DE60010358 T DE 60010358T DE 60010358 D1 DE60010358 D1 DE 60010358D1
Authority
DE
Germany
Prior art keywords
ibdv
cell culture
bursal disease
infectious bursal
disease virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60010358T
Other languages
English (en)
Other versions
DE60010358T2 (de
Inventor
Adriaan Antonius Wilhelmus Maria Loon
Egbert Mundt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60010358D1 publication Critical patent/DE60010358D1/de
Publication of DE60010358T2 publication Critical patent/DE60010358T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60010358T 1999-03-05 2000-02-28 Infectiösenbursalkrankheitsvirus (IBDV) die an Zellkultur angepasst sind Expired - Lifetime DE60010358T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200647 1999-03-05
EP99200647 1999-03-05

Publications (2)

Publication Number Publication Date
DE60010358D1 true DE60010358D1 (de) 2004-06-09
DE60010358T2 DE60010358T2 (de) 2004-09-23

Family

ID=8239949

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60010358T Expired - Lifetime DE60010358T2 (de) 1999-03-05 2000-02-28 Infectiösenbursalkrankheitsvirus (IBDV) die an Zellkultur angepasst sind

Country Status (14)

Country Link
US (2) US6492148B1 (de)
EP (1) EP1035203B1 (de)
JP (2) JP4675447B2 (de)
KR (1) KR100709077B1 (de)
AT (1) ATE266097T1 (de)
BR (1) BR0001011B1 (de)
CA (1) CA2298956C (de)
DE (1) DE60010358T2 (de)
DK (1) DK1035203T3 (de)
ES (1) ES2220333T3 (de)
HU (1) HU226254B1 (de)
PL (1) PL198981B1 (de)
PT (1) PT1035203E (de)
ZA (1) ZA200001069B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136232A0 (en) * 2000-05-18 2001-05-20 Bar Ilan University Res Author Measurements of enzymatic activity in a single, individual cell in population
EP1421222A4 (de) * 2001-03-09 2004-07-07 Univ California Zellkultursystem zur synthese von infektiösem hepatitis-c-virus
US20050014201A1 (en) * 2001-10-25 2005-01-20 Mordechai Deuthsch Interactive transparent individual cells biochip processor
IL154677A0 (en) * 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
US8597597B2 (en) 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
US7888110B2 (en) 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
EP1654347B1 (de) * 2003-06-26 2014-06-04 Seng Enterprises Limited Verbesserte Materialien zur Konstruktion von Zellchips, Zellchip-Abdeckungen, Zellchip-Hüllen, prozessierte Zellchips und Verwendungen davon
US7982751B2 (en) * 2003-07-11 2011-07-19 The University Of North Carolina Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
US20050064524A1 (en) * 2003-08-11 2005-03-24 Mordechai Deutsch Population of cells utilizable for substance detection and methods and devices using same
US7544805B2 (en) * 2004-02-03 2009-06-09 Chemagis Ltd. Stable amorphous forms of montelukast sodium
EP1763665A1 (de) * 2004-07-07 2007-03-21 Seng Enterprises Limited Verfahren und vorrichtung zur identifizierung eines vertiefungsbildes auf einem bild einer komponente mit vertiefungen
US7403647B2 (en) * 2004-09-13 2008-07-22 Seng Enterprises Ltd. Method for identifying an image of a well in an image of a well-bearing component
EP1781404A2 (de) * 2004-08-25 2007-05-09 Seng Enterprises Limited Verfahren und vorrichtung zur isolierung von zellen
US8038964B2 (en) 2005-01-25 2011-10-18 Seng Enterprises Ltd. Device for studying individual cells
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
US8288120B2 (en) 2005-11-03 2012-10-16 Seng Enterprises Ltd. Method for studying floating, living cells
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
EP2237887A2 (de) 2007-12-26 2010-10-13 Seng Enterprises Ltd. Vorrichtung zur untersuchung von lebenden zellen
EP2407534A1 (de) 2010-07-14 2012-01-18 Neo Virnatech, S.L. Verfahren und Reagenzien zum Erhalt von transkriptionell aktiven virusähnlichen Artikeln und rekombinante Virionen
CN102258777B (zh) * 2011-06-30 2012-09-26 河南农业大学禽病研究所 用鸡胚源细胞系繁殖传染性法氏囊病毒制备灭活疫苗和联苗的方法
CN111235117B (zh) * 2020-02-13 2021-08-27 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一株自然适应体外细胞培养的鸡传染性法氏囊病病毒经典株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
PL338773A1 (en) 2000-09-11
ZA200001069B (en) 2000-10-20
CA2298956C (en) 2009-12-01
KR100709077B1 (ko) 2007-04-19
PL198981B1 (pl) 2008-08-29
DK1035203T3 (da) 2004-08-30
EP1035203B1 (de) 2004-05-06
JP2000312593A (ja) 2000-11-14
HU226254B1 (en) 2008-07-28
HUP0000992A2 (hu) 2000-11-28
BR0001011A (pt) 2001-07-03
JP4675447B2 (ja) 2011-04-20
DE60010358T2 (de) 2004-09-23
JP2011036255A (ja) 2011-02-24
HUP0000992A3 (en) 2005-06-28
PT1035203E (pt) 2004-08-31
US6569422B1 (en) 2003-05-27
HU0000992D0 (en) 2000-05-28
ATE266097T1 (de) 2004-05-15
KR20010069175A (ko) 2001-07-23
BR0001011B1 (pt) 2011-05-17
ES2220333T3 (es) 2004-12-16
CA2298956A1 (en) 2000-09-05
US6492148B1 (en) 2002-12-10
EP1035203A1 (de) 2000-09-13

Similar Documents

Publication Publication Date Title
DE60010358D1 (de) Infectiösenbursalkrankheitsvirus (IBDV) die an Zellkultur angepasst sind
DE69133597D1 (de) Cytoplasmatische männliche Sterilität verleihende Dna-Sequenz, mitochondriales Genom, nukleäres Genom, Mitochondrien und diese Sequenz enthaltende Pflanze, und Verfahren zur Herstellung von Hybriden
CA2154023A1 (en) Recombinant infectious non-segmented negative strand rna virus
HUP0000188A2 (hu) Immortalizált sejtvonalak vírusszaporításra
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
NZ326555A (en) Inhibitors of interleukin-1beta converting enzyme (ICE)
ATE318913T1 (de) System zum exprimieren einer hyperthermostabilen protease
NZ319786A (en) HCV NS3 protein fragments with helicase activity and improved solubility
DE60004217D1 (de) Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
NO895028L (no) Ny chimerisk transformerende vekstfaktor-beta.
DE69329500D1 (de) Ein verfahren zur herstellung von immunosuppressiva und eine neuartige mikrobielle spezies, die dabei eingesetzt wird
DE69427955T2 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
ATE187496T1 (de) Equine herpesviren (ehv), die fremd-dna enthalten, verfahren zu ihrer herstellung und ihre verwendung in impfstoffen
DE69404615D1 (de) Verfahren zur Herstellung 1,2-Benzisothiazol-3-one
CA2329510A1 (en) Promoter sequence which is expressed in anthers and in pollen
EP0747475A3 (de) Zusammengesetzter Objektträger für biologische Züchtung
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
DE69331216D1 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
DE69939751D1 (de) Verfahren zur Herstellung von S-Aryl-Cystein
DE69014644D1 (de) Somatische embryogenese von kürbissen.
DE60036198D1 (de) Transgener mollusk und verfahren zu seiner herstellung
WO2001068863A3 (fr) Sequences polynucleotidiques purifiees de plantes et de levure codant pour des proteines qui interagissent avec les produits du genome des geminivirus
DE68913212D1 (de) Ein reines faktor i-protein und verfahren zur herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL